Aristeia Capital (IRAB) files Schedule 13G for 1.15M Units stake
Rhea-AI Filing Summary
Iris Acquisition Corp II reports a Schedule 13G filing showing Aristeia Capital, L.L.C. beneficially owns 1,152,750 Units. The filing states this equals 6.67% of the Class A ordinary shares outstanding, based on 17,288,000 shares outstanding as of March 26, 2026. The reported position carries sole voting and sole dispositive power for all 1,152,750 Units and is signed by Andrew B. David as COO of Aristeia Capital, L.L.C.
Positive
- None.
Negative
- None.
Insights
Aristeia holds a meaningful minority stake (6.67%) disclosed via Schedule 13G.
The filing documents an institutional beneficial ownership position of 1,152,750 Units representing 6.67% of outstanding shares as of March 26, 2026. The Schedule 13G format indicates a passive investor reporting regime rather than an active Schedule 13D takeover posture.
Key dependencies include the issuer's outstanding share count cited from the 10-K and the trustee/issuer unit structure; subsequent filings could update ownership percentages or voting arrangements.
Filing shows sole voting and dispositive authority for the reported Units.
The Schedule 13G lists sole power to vote and to dispose of 1,152,750 Units, so the reporting entity exercises direct control over those securities. The CUSIP G4940M125 and the issuer address are provided in the filing.
Material changes would appear in amendments to the 13G or a switch to Schedule 13D; timing and any future transfers are not disclosed here.
Key Figures
Key Terms
Schedule 13G regulatory
Units financial
Beneficially owned regulatory
Dispositive power regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.